Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
WC

Wenying Chai — 31 Patents

Johnson & Johnson: 26 patents #315 of 7,810Top 5%
OPOrtho-Mcneil Pharmaceutical: 5 patents #82 of 449Top 20%
San Diego, CA: #1,257 of 23,606 inventorsTop 6%
California: #16,606 of 386,348 inventorsTop 5%
Overall (All Time): #115,823 of 4,157,543Top 3%
31 Patents All Time
Wenying Chai has been granted 31 US patents while listed as an inventor at Johnson & Johnson. The first was granted in 2001 and the most recent in August 2025. Wenying Chai ranks #115,823 of 4,157,543 US inventors in our database (top 2.8%). Patent records list Wenying Chai in San Diego, CA, US.

Patents per Year

Patents granted per year, 2001 to 2025Bar chart with a peak of 4 patents in 2015.peak 42001: 1 patents20012003: 1 patents2004: 2 patents20042005: 1 patents2008: 2 patents20082011: 1 patents2012: 1 patents20122014: 2 patents2015: 4 patents20152016: 1 patents2017: 3 patents20172018: 1 patents2019: 1 patents20192021: 4 patents2022: 2 patents20222023: 2 patents2024: 1 patents20242025: 1 patents2025

Issued Patents All Time

Showing 1–25 of 31 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12378254 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators Michael A. Letavic, Kiev S. Ly, Daniel J. Pippel, Dale A. Rudolph, Kathleen C. Sappey +6 more 2025-08-05
11897900 Inhibitors of KEAP1-Nrf2 protein-protein interaction J. Kent Barbay, Gavin Hirst, Kevin D. Kreutter, David A. Kummer, Kelly J. McClure +5 more 2024-02-13 $332,761,000
11827638 Imidazopyrrolopyridine as inhibitors of the JAK family of kinases Genesis M. Bacani, Tatiana Koudriakova, Paul J. Krawczuk, Kevin D. Kreutter, Kristi A. Leonard +6 more 2023-11-28 $131,962,000
11667644 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators Michael A. Letavic, Kiev S. Ly, Daniel J. Pippel, Dale A. Rudolph, Kathleen C. Sappey +6 more 2023-06-06 $206,373,000
11427601 Inhibitors of KEAP1-Nrf2 protein-protein interaction J. Kent Barbay, Gavin Hirst, Kevin D. Kreutter, David A. Kummer, Kelly J. McClure +5 more 2022-08-30 $641,310,000
11254673 Small molecule inhibitors of NF-κB inducing kinase J. Kent Barbay, Wendy Eccles, Michael D. Hack, Aaron T. Herrmann, William M. Jones +6 more 2022-02-22 $192,742,000
RE48841 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators Michael A. Letavic, Kiev S. Ly, Daniel J. Pippel, Dale A. Rudolph, Kathleen C. Sappey +6 more 2021-12-07
11059828 Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulators Michael A. Letavic, Kiev S. Ly, Daniel J. Pippel, Dale A. Rudolph, Kathleen C. Sappey +6 more 2021-07-13 $130,196,000
10981911 Imidazopyrrolopyridine as inhibitors of the JAK family of kinases Genesis M. Bacani, Tatiana Koudriakova, Paul J. Krawczuk, Kevin D. Kreutter, Kristi A. Leonard +6 more 2021-04-20 $98,264,000
10947252 Inhibitors of KEAP1-Nrf2 protein-protein interaction J. Kent Barbay, Gavin Hirst, Kevin D. Kreutter, David A. Kummer, Kelly J. McClure +5 more 2021-03-16 $128,294,000
10172856 2,4-diaminopyrimidine derivatives as histamine H4 modulators Genesis M. Bacani, James P. Edwards, Russell C. Smith, Mark S. Tichenor, Jennifer D. Venable +1 more 2019-01-08 $79,972,000
9981909 Serotonin receptor modulators Nicholas I. Carruthers, Jill A. Jablonowski, Chandravadan R. Shah, Brock T. Shireman, Devin M. Swanson +2 more 2018-05-29 $56,746,000
9695149 1,2,6-substituted benzimidazoles as flap modulators Curt A. Dvorak, Wendy Eccles, James P. Edwards, Steven Goldberg, Paul J. Krawczuk +7 more 2017-07-04
9682971 1,2,5-Substituted benzimidazoles as flap modulators Charlotte Pooley Deckhut, Curt A. Dvorak, Wendy Eccles, James P. Edwards, Steven Goldberg +5 more 2017-06-20 $117,780,000
9682972 1,2,5-substituted benzimidazoles as flap modulators Charlotte Pooley Deckhut, Curt A. Dvorak, Wendy Eccles, James P. Edwards, Steven Goldberg +5 more 2017-06-20 $117,780,000
9265770 1,2,5-substituted benzimidazoles as FLAP modulators Charlotte Pooley Deckhut, Curt A. Dvorak, Wendy Eccles, James P. Edwards, Steven Goldberg +5 more 2016-02-23 $58,494,000
9089569 1,2,6-substituted benzimidazoles as flap modulators Curt A. Dvorak, Wendy Eccles, James P. Edwards, Steven Goldberg, Paul J. Krawczuk +7 more 2015-07-28 $45,878,000
9079911 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators Michael A. Letavic, Kiev S. Ly, Daniel J. Pippel, Dale A. Rudolph, Kathleen C. Sappey +6 more 2015-07-14 $42,716,000
9067917 1,2,5-substituted benzimidazoles as FLAP modulators Charlotte Pooley Deckhut, Curt A. Dvorak, Wendy Eccles, James P. Edwards, Steven Goldberg +5 more 2015-06-30 $80,032,000
8952177 1,2,6-substituted benzimidazoles as FLAP modulators Curt A. Dvorak, Wendy Eccles, James P. Edwards, Steven Goldberg, Paul J. Krawczuk +7 more 2015-02-10 $112,846,000
8653263 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators Michael A. Letavic, Kiev S. Ly, Daniel J. Pippel, Dale A. Rudolph, Kathleen C. Sappey +6 more 2014-02-18 $79,615,000
8642583 Serotonin receptor modulators Nicholas I. Carruthers, Jill A. Jablonowski, Chandravadan R. Shah, Brock T. Shireman, Devin M. Swanson +2 more 2014-02-04 $69,352,000
8183239 Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptor Pascal Bonaventure, Nicholas I. Carruthers, Curt A. Dvorak, Jill A. Jablonowski, Dale A. Rudolph +4 more 2012-05-22 $75,331,000
7897771 Fused heterocyclic compounds Nicholas I. Carruthers, Xiaohu Deng, Curt A. Dvorak, Annette Kwok, Jimmy T. Liang +3 more 2011-03-01 $34,623,000
7402680 Fused heterocyclic compounds Nicholas I. Carruthers, Xiaohu Deng, Curt A. Dvorak, Annette Kwok, Jimmy T. Liang +3 more 2008-07-22 $294,225,000